Founder
09/03/2023 13:06
March 9 (Reuters) - Ocean Biomedical Inc OCEA.O :
* OCEAN BIOMEDICAL (NASDAQ: OCEA) SHARES DETAILED RESEARCH
DATA ON
ANTI-TUMOR PATHWAY DISCOVERIES AND THEIR POTENTIAL FOR TREATMENT
OF NON-SMALL CELL LUNG CANCER, METASTATIC MELANOMA, AND
GLIOBLASTOMA BY SCIENTIFIC CO-FOUNDER
Source text for Eikon: ID:nGNX2RTpLR
Further company coverage: OCEA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ocean Biomedical
See all newsTrump's shipbuilding plan could upend ocean cargo industry, companies warn
Brief: Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer
Brief: Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q
Brief: Ocean Biomedical receives Nasdaq staff determination letter
Brief: Ocean Biomedical- Ratified Fully Countersigned Copy Of Revised Agreement With Virion Therapeutics Received On Sept 26